Paul Nathan

Paul Nathan

Auto-generated profile, based on publicly available information

Paul Nathan

Mount Vernon Cancer Centre, Northwood, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in PharmacoEconomics - Open
Verified
Journal Article
Open access
PDF file
ABAsh Bullement
Ash Bullement
PNPaul Nathan
Paul Nathan
AWAnna Willis
Anna Willis
AAAmerah Amin
Amerah Amin
CLCameron Lilley
Cameron Lilley
MBMurtuza F Bharmal
Murtuza F Bharmal
Metastatic Merkel cell carcinoma (mMCC) is a rare and aggressive skin cancer. Until recently, there were no licensed treatment options for patients with mMCC, and prognosis was poor. A cost-effectiveness analysis was conducted for avelumab, a newly available treatment option for mMCC, versus standard care (SC), from a UK National Health Service perspective.